UFP
Technologies, Inc. (Nasdaq: UFPT), a manufacturer of packaging and
component products, today reported net income of $2.1 million or $0.29
per diluted common share outstanding for its third quarter ended
September 30, 2014, compared to net income of $2.9 million or $0.41 per
diluted common share outstanding for the same period in 2013. Sales for
the third quarter were $35.4 million compared to third quarter 2013
sales of $34.7 million. Net income for the nine-month period ended
September 30, 2014, was $6.0 million or $0.84 per diluted common share
outstanding compared to $7.9 million or $1.11 per diluted common share
outstanding for the same period of 2013. Sales for the nine-month period
ended September 30, 2014, were $104.0 million, compared to sales of
$104.2 million for the same period in 2013.
“We experienced modest sales growth in Q3, as continued strength in our
medical market and an uptick in military orders helped offset a decline
in our automotive market,” said R. Jeffrey Bailly, Chairman & CEO. “As
expected, our operating results were impacted by a number of important
strategic initiatives designed to optimize our platform and position us
for long-term growth.”
“We have made great progress on these initiatives, and put many of these
one-time expenses behind us,” Bailly continued. “For example, our
Midwest consolidation is complete and our California consolidation is
well underway. In Texas, our new molded fiber operation is up and
running, and we are now incorporating our local foam fabrication plant
into that facility as well. In addition, two more plants recently came
online with our new ERP system, which should enhance our business in a
number of critical ways.”
“Our ability to execute all these initiatives at once is a testament to
the strength and depth of our management team,” Bailly said. “As we
continue to complete them in a timely manner, we expect improved results
to follow.”
UFP Technologies is a producer of innovative custom-engineered
components, products, and specialty packaging. Using foams, plastics,
composites, and natural fiber materials, the Company designs and
manufactures a vast range of solutions primarily for the medical,
automotive, aerospace and defense, and packaging markets. The UFP team
acts as an extension of our customers’ in-house research, engineering,
and manufacturing groups, working closely with them to solve their most
complex product and packaging challenges.
This news release contains statements relating to expected financial
performance and/or future business prospects, events and plans that are
forward-looking statements. Such statements include, without limitation,
statements about the Company’s prospects, anticipated trends in the
different markets in which the Company competes, including the molded
fiber, medical, military and automotive markets, anticipated advantages
relating to the Company’s decisions to consolidate its Midwest and
California facilities and the expected costs savings and efficiencies
associated therewith, anticipated advantages of maintaining fewer,
larger plants, anticipated advantages the Company expects to realize
from its investments and capital expenditures, including the development
of and investments in its molded fiber product lines, anticipated
advantages the Company expects to realize as a result of its new ERP
software system, expectations regarding the manufacturing capacity and
efficiencies of the Company’s new production equipment, statements about
the Company’s acquisition opportunities and strategies, its
participation and growth in multiple markets, its business
opportunities, the Company’s growth potential and strategies for growth,
anticipated revenues and the timing of such revenues, and any indication
that the Company may be able to sustain or increase its sales and
earnings or sales and earnings growth rates. Investors are cautioned
that such forward-looking statements involve risks and uncertainties,
including without limitation risks associated with the implementation of
new production equipment in a timely, cost-efficient manner, risks that
any benefits from such new equipment may be delayed or not fully
realized, or that the Company may be unable to fully utilize its
expected production capacity, risks and uncertainties associated with
plant closures and expected efficiencies from consolidating
manufacturing, the identification of suitable acquisition candidates and
the successful, efficient execution of acquisition transactions and
integration of any such acquisition candidates, as well as other risks
and uncertainties that are detailed in the documents filed by the
Company with the Securities and Exchange Commission (“SEC”).
Accordingly, actual results may differ materially. Readers are referred
to the documents filed by the Company with the SEC, specifically the
last reports on Forms 10-K and 10-Q. The forward-looking statements
contained herein speak only of the Company’s expectations as of the date
of this press release. The Company expressly disclaims any obligation or
undertaking to release publicly any updates or revisions to any such
statement to reflect any change in the Company’s expectations or any
change in events, conditions, or circumstances on which any such
statement is based.
Consolidated Condensed Statement of Income
|
(in thousands, except per share data)
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
|
2014
|
|
|
|
|
|
2013
|
|
|
|
|
|
2014
|
|
|
|
|
|
2013
|
|
Net sales
|
|
|
$
|
35,406
|
|
|
|
|
$
|
34,700
|
|
|
|
|
$
|
104,040
|
|
|
|
|
$
|
104,229
|
|
Cost of sales
|
|
|
|
25,723
|
|
|
|
|
|
24,538
|
|
|
|
|
|
75,773
|
|
|
|
|
|
74,445
|
|
Gross profit
|
|
|
|
9,683
|
|
|
|
|
|
10,162
|
|
|
|
|
|
28,267
|
|
|
|
|
|
29,784
|
|
SG&A
|
|
|
|
5,871
|
|
|
|
|
|
5,678
|
|
|
|
|
|
18,161
|
|
|
|
|
|
17,700
|
|
Restructuring costs
|
|
|
|
772
|
|
|
|
|
|
-
|
|
|
|
|
|
1,096
|
|
|
|
|
|
-
|
|
(Gain) loss on sale of fixed assets
|
|
|
|
(58
|
)
|
|
|
|
|
-
|
|
|
|
|
|
(70
|
)
|
|
|
|
|
11
|
|
Operating income
|
|
|
|
3,098
|
|
|
|
|
|
4,484
|
|
|
|
|
|
9,080
|
|
|
|
|
|
12,073
|
|
Interest expense
|
|
|
|
(20
|
)
|
|
|
|
|
(43
|
)
|
|
|
|
|
(69
|
)
|
|
|
|
|
(128
|
)
|
Other income
|
|
|
|
101
|
|
|
|
|
|
-
|
|
|
|
|
|
201
|
|
|
|
|
|
-
|
|
Income before income taxes
|
|
|
|
3,179
|
|
|
|
|
|
4,441
|
|
|
|
|
|
9,212
|
|
|
|
|
|
11,945
|
|
Income taxes
|
|
|
|
1,113
|
|
|
|
|
|
1,554
|
|
|
|
|
|
3,224
|
|
|
|
|
|
4,046
|
|
Net income from consolidated operations
|
|
|
$
|
2,066
|
|
|
|
|
$
|
2,887
|
|
|
|
|
$
|
5,988
|
|
|
|
|
$
|
7,899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share outstanding
|
|
|
$
|
0.29
|
|
|
|
|
$
|
0.42
|
|
|
|
|
$
|
0.85
|
|
|
|
|
$
|
1.16
|
|
Net income per diluted share outstanding
|
|
|
$
|
0.29
|
|
|
|
|
$
|
0.41
|
|
|
|
|
$
|
0.84
|
|
|
|
|
$
|
1.11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding
|
|
|
|
7,055
|
|
|
|
|
|
6,840
|
|
|
|
|
|
7,018
|
|
|
|
|
|
6,802
|
|
Weighted average diluted shares outstanding
|
|
|
|
7,186
|
|
|
|
|
|
7,112
|
|
|
|
|
|
7,170
|
|
|
|
|
|
7,096
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Condensed Balance Sheets
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2014
|
|
|
|
2013
|
Assets:
|
|
|
(unaudited)
|
|
|
|
|
Cash
|
|
|
$
|
33,048
|
|
|
|
$
|
37,303
|
Receivables
|
|
|
|
18,565
|
|
|
|
|
17,032
|
Inventories
|
|
|
|
13,500
|
|
|
|
|
11,048
|
Other current assets
|
|
|
|
3,060
|
|
|
|
|
3,449
|
Net property, plant, and equipment
|
|
|
|
33,539
|
|
|
|
|
25,507
|
Other assets
|
|
|
|
10,426
|
|
|
|
|
10,681
|
Total assets
|
|
|
$
|
112,138
|
|
|
|
$
|
105,020
|
Liabilities and equity:
|
|
|
|
|
|
|
|
Short-term debt
|
|
|
$
|
989
|
|
|
|
$
|
976
|
Accounts payable
|
|
|
|
5,269
|
|
|
|
|
3,081
|
Other current liabilities
|
|
|
|
7,001
|
|
|
|
|
8,265
|
Long-term debt
|
|
|
|
2,123
|
|
|
|
|
2,867
|
Other liabilities
|
|
|
|
3,753
|
|
|
|
|
4,241
|
Total liabilities
|
|
|
|
19,135
|
|
|
|
|
19,430
|
Total equity
|
|
|
|
93,003
|
|
|
|
|
85,590
|
Total liabilities and stockholders' equity
|
|
|
$
|
112,138
|
|
|
|
$
|
105,020
|
Copyright Business Wire 2014